期刊文献+

胃癌个体化治疗新进展 被引量:8

下载PDF
导出
摘要 胃癌是世界范围难治性肿瘤之一,虽然国内外许多学者开展了大量的探索研究癌的总生存率改善有限。不同地区、不同人群的胃癌临床特点各不相同,需要在个体化治疗基础上的规范治疗。本文就近年来胃癌个体化治疗的新进展作一介绍。
作者 李玉升
出处 《癌症进展》 2009年第5期500-505,共6页 Oncology Progress
  • 相关文献

参考文献27

  • 1Boose D, Badgwell B, Cormier JN, et al. Association of neoadjuvant chemoradiation with improved survival in resectable gastric cancer. 2009 ASCO GI Cancers Symposium, Abstr 76.
  • 2Mailey BA, Sun C, Artinyan A, et al. Relative outcomes for Asian - Americans with gastricarcinoma. 2009 ASCO GI Cancer Symposium, Abstr 3.
  • 3Ott K, Becker K, Langer R, et al. Correlation of histopathological response to neoadjuvant chemotherapy (CTx) in the primary tumor and in lymph node mestastatic with outcome in 686 patients with gastric (GC) and esophageal adenocarcinoma (AEGI). 2009 ASCO GI Cancer Symposium, Abstr 42.
  • 4Roth AD, Zalcberg JR, WU C, et al. Registryof gastric cancer treatment evaluation (REGATE). 2009 ASCO GI Cancer Symposium, Abstr 43.
  • 5Terashima M, Bando E, Kawamura T, et al. Evaluation of the significace of lymph node staging for gastric cancer as a function of tumor location. 2009 ASCO GI Cancer Symposium, Abstr 56.
  • 6Van de Velde CJH. Current role of surgery and multimodal treatment in localized gastric cancer [ J ]. Annals of Oncology, 2008, 19 (suppl 5): v93.
  • 7Macdonald JS, Smalley S, Benedetti J, et al. Postoperative combined radiation and chemotherapy improves disease - free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomuch and gastroesophageal junction: Updata of the resuh of intergroup study INT - 0116 (SWOG 9008). 2004 ASCO GI Cancer Symposium, Abstr 6.
  • 8Cunningham D, Allum WH, Stenning SP, et al. Preoperative chemotherapy versus surgery alone for respectable gastroeophagerl cancer [ J ]. N Engl J Med, 2006, 255 (1):11.
  • 9Ychou M, Pignon JP, Lasser P, et al. Phase III prelimminary results of preoperative fluorouracil (F) and cisplatin (P) versus surgery alone in adenocarcinoma of stumach and lower esophagus (ASLE): FNLCC 94012 - FFCD 9703 Trial [J]. JCO, 2006, 24 (18 suppl):4026.
  • 10Cunningham D, Oliveira J. ESMO clinical recommendations for dignosis, treatment and follow - up [ J ]. Annals of Oncology, 2008, 19 (suppl 2): 123.

二级参考文献4

  • 1Pakin DM, Pisani P, Ferlay J. Estimates of the worldwise incidence of 25 major cancer in 1990 [J]. Int J Cancer, 1999, 80(6):827-841.
  • 2Pakin DM,Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(25):74-108.
  • 3Pakin DM, Pisani P, Ferlay J. Global Cancer Statistics[J]. CA Cancer J Clin, 1999, 49(1):33-64.
  • 4Pakin DM, Bray FI, Devesa SS, et al. Cancer burden in the year 2000. The global picture[J]. Eur J Cancer, 2001, 37(Suppl 8):4-66.

共引文献19

同被引文献63

  • 1徐玲,郭勇.胃癌常用中医治法的研究概述[J].世界中医药,2007,2(5):314-317. 被引量:3
  • 2赵兴.参芪扶正注射液减轻肿瘤放化疗毒副反应的临床观察[J].中国中西医结合杂志,2004,24(9):857-858. 被引量:38
  • 3杨桦,金壮,赫甡,马占宝.人参皂甙与免疫核糖核酸对癌基因表达的协同抑制作用[J].中国医科大学学报,1993,22(4):255-258. 被引量:209
  • 4孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2009.
  • 5中华人民共和国卫生部医政司,中国常见恶性肿瘤诊治规范(合订本)[M].北京:北京医科大学中国协和医科大学联合出版社,1991:5-12,10-15.
  • 6Greenlee RT,Murray T,Bolden S,et al.Cancer statistics,2000[J].CA Cancer J Clin,2000,50(1):7-33.
  • 7周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2005:601~610.
  • 8贺用和 林洪生.中药与化疗结合治疗癌症的进展.中华新医学,2002,3(4):355-357.
  • 9Kondo K,Chin K,Sakamoto J. A multicentre phase II trial using 4-week cycles of capecitabine in advanced/metastatic gastric cancer ( AGC ) [ J ]. Proc Am Soc Clin Oncol, 2003,22 ( 5 ) : 321 ( Abstr: 1289 ).
  • 10KangYK, KangWK, ShinDB, et al. Capecitabine/sisplatinversusS-fluorou- racil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomized phase 11 noninferiority trim [ J ]. Ann Oncol, 2009, 20 ( 8 ) :666 - 673.

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部